NCT01054092View on ClinicalTrials.gov

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

January 14, 2010

Primary Completion Date

July 22, 2011

Study Completion Date

July 22, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

Trial Locations (7)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01054092 - A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients | Biotech Hunter | Biotech Hunter